Cargando…

286P Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response

Detalles Bibliográficos
Autores principales:	Body, A., Ahern, E.S., Lal, L., Abdulla, H., Opat, S., Downie, P., Leahy, M., Fuentes-Bolanos, N., Padhye, B., Hamad, N., Milch, V., Segelov, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719676/ http://dx.doi.org/10.1016/j.annonc.2022.10.312

Ejemplares similares

1611P Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer
por: Segelov, E., et al.
Publicado: (2022)

Rapid Protocol Development, Study Startup and Enrolment of a Prospective Study of COVID-19 Vaccination for Patients with Cancer: A Collaborative Approach
por: Body, Amy, et al.
Publicado: (2022)

Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET)
por: Body, Amy, et al.
Publicado: (2022)

286. Infectious Complications and Antimicrobial Utilization in Hospitalized Patients with COVID-19
por: Hunter Fraker, J, et al.
Publicado: (2021)

286 COVID-19 Pandemic as a barrier to cervical cancer screening in brazil
por: Glimm, D., et al.
Publicado: (2022)

2.86 The Impact of COVID-19 on School Mental Health Services
por: Rogers, Kenneth M.
Publicado: (2022)

286 Effect of the COVID-19 Pandemic on Emergency Department Adult Psychiatric Visits
por: Bauman, C., et al.
Publicado: (2021)

POSA286 Early Experience with Health Technology Assessments for COVID-19 Treatments
por: Sitavu-Radu, X, et al.
Publicado: (2022)

Thromboembolism after COVID-19 Vaccination: A Systematic Review of Such Events in 286 Patients
por: Mani, Avinash, et al.
Publicado: (2022)

COVID-19 vaccination and breakthrough infections in patients with cancer
por: Schmidt, A.L., et al.
Publicado: (2022)

286. Prevalence and Clinical Outcomes of COVID-Associated Pulmonary Fibrosis
por: Vogler, Andrew J, et al.
Publicado: (2022)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

286 Trends in Trauma Admissions and Severity at a Level II Trauma Center During the COVID-19 Pandemic
por: Hartman, R., et al.
Publicado: (2022)

Outcomes of Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies
por: Chien, Kelly S., et al.
Publicado: (2022)

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
por: Chien, Kelly S., et al.
Publicado: (2023)

Fulminant Reversible Cerebral Vasoconstriction Syndrome in Breakthrough COVID 19 Infection
por: Ray, Somdattaa, et al.
Publicado: (2022)

Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic
por: Alcendor, Donald J., et al.
Publicado: (2022)

Breakthrough of COVID-19 using radiotherapy treatment modalities()
por: Venkatraman, P., et al.
Publicado: (2020)

Hospitalisation among vaccine breakthrough COVID-19 infections
por: Juthani, Prerak V, et al.
Publicado: (2021)

Breakthrough medicines during the COVID-19 pandemic era
por: Ghali, Eswara Naga Hanuma Kumar, et al.
Publicado: (2022)

Metabolic disorders, COVID-19 and vaccine-breakthrough infections
por: Stefan, Norbert
Publicado: (2021)

Clinical characterization of COVID-19 breakthrough infections, Philippines
por: Velasco, John Mark, et al.
Publicado: (2022)

The “identikit” of subject with obesity and COVID-19 vaccine breakthrough
por: Muscogiuri, Giovanna, et al.
Publicado: (2022)

Breakthrough COVID-19 infections – Analyzing our experience
por: Hussain, Aneela, et al.
Publicado: (2023)

Health Tract, No. 286: Bread Making
Publicado: (1867)

P286 Histoplasmosis in Sri Lanka
por: Sigera, Liyanage Shamithra Madhumali, et al.
Publicado: (2022)

COVID-19 breakthrough infections in rheumatic diseases patients after vaccination
por: Alshukairi, Abeer N., et al.
Publicado: (2022)

A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance
por: Ahn, Byeong Yun, et al.
Publicado: (2020)

Vaccine Breakthrough Severe COVID-19 in a Lung Recipient
por: Beyoglu, Muhammet Ali, et al.
Publicado: (2022)

VACCINATED WITH A TWIST: BREAKTHROUGH COVID-19 IN AN IMMUNOCOMPROMISED PATIENT
por: DAOUD, DANA, et al.
Publicado: (2021)

Archetype of Olfactory and Gustatory Dysfunction in Breakthrough COVID-19 Illness
por: Sagar, Prem, et al.
Publicado: (2021)

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
por: Bergwerk, Moriah, et al.
Publicado: (2021)

Predictors of death in COVID-19 vaccine breakthrough infections in Brazil
por: Estofolete, Cassia Fernanda, et al.
Publicado: (2022)

Why do breakthrough COVID-19 infections occur in the vaccinated?
por: Maclean, Patrick, et al.
Publicado: (2021)

COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel
por: Yekutiel, Naama, et al.
Publicado: (2023)

Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities
por: Smits, Peter D., et al.
Publicado: (2023)

COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients
por: Zhang, Xiaojing, et al.
Publicado: (2022)

Immune Responses and Breakthrough Infections After COVID-19 Vaccination
por: Kwon, Ki Tae
Publicado: (2023)

Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
por: Skwarek, Aleksandra, et al.
Publicado: (2021)

COVID-19 recovery: implications for cancer care clinicians
por: Delany, Clare, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kcc9sad70mhd7jtdac2p2e10t7